The MENDS2 trial was intended as a study comparing dexmedetomidine to propofol. However, the doses of these medications used in the study weren't high enough to be impactful. In retrospect, the study may actually be an investigation of how clinicians approach the agitated intubated patient – potentially revealing an over-reliance on opioid infusions.
EMCrit Project by Josh Farkas.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου